Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer). [electronic resource]
Producer: 19990216Description: 511-8 p. digitalISSN:- 0305-7453
- Antineoplastic Agents -- adverse effects
- Cefepime
- Cephalosporins -- administration & dosage
- Cilastatin -- administration & dosage
- Drug Therapy, Combination -- administration & dosage
- Fever -- chemically induced
- Humans
- Imipenem -- administration & dosage
- Neoplasms -- drug therapy
- Neutropenia -- chemically induced
- Risk Factors
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.